PL2540298T3 - Powlekany stały preparat - Google Patents

Powlekany stały preparat

Info

Publication number
PL2540298T3
PL2540298T3 PL11747495T PL11747495T PL2540298T3 PL 2540298 T3 PL2540298 T3 PL 2540298T3 PL 11747495 T PL11747495 T PL 11747495T PL 11747495 T PL11747495 T PL 11747495T PL 2540298 T3 PL2540298 T3 PL 2540298T3
Authority
PL
Poland
Prior art keywords
solid preparation
coated solid
coated
preparation
solid
Prior art date
Application number
PL11747495T
Other languages
English (en)
Polish (pl)
Inventor
Yuki Fujisaki
Ryoji Yoshii
Yasuhide Horiuchi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of PL2540298T3 publication Critical patent/PL2540298T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11747495T 2010-02-26 2011-02-25 Powlekany stały preparat PL2540298T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010042066 2010-02-26
PCT/JP2011/054256 WO2011105539A1 (fr) 2010-02-26 2011-02-25 Préparation solide enrobée
EP11747495.7A EP2540298B1 (fr) 2010-02-26 2011-02-25 Préparation solide enrobée

Publications (1)

Publication Number Publication Date
PL2540298T3 true PL2540298T3 (pl) 2016-04-29

Family

ID=44506936

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11747495T PL2540298T3 (pl) 2010-02-26 2011-02-25 Powlekany stały preparat

Country Status (14)

Country Link
US (1) US8658208B2 (fr)
EP (1) EP2540298B1 (fr)
JP (1) JP5761018B2 (fr)
KR (1) KR101445671B1 (fr)
CN (1) CN102762205B (fr)
BR (1) BR112012015923A2 (fr)
CA (1) CA2785694C (fr)
ES (1) ES2552628T3 (fr)
HU (1) HUE026633T2 (fr)
MX (1) MX344141B (fr)
PL (1) PL2540298T3 (fr)
SI (1) SI2540298T1 (fr)
TW (1) TWI480067B (fr)
WO (1) WO2011105539A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI438012B (zh) 2008-12-25 2014-05-21 Toray Industries 固態製劑用之塗覆劑及使用其之固態製劑
WO2013045961A1 (fr) * 2011-09-29 2013-04-04 Meditop Gyógyszeripari Kft. Composition d'enrobage
KR101278572B1 (ko) * 2011-10-18 2013-06-25 주식회사 네비팜 류코트리엔 길항제와 에피나스틴의 복합제제
CN102973532A (zh) * 2012-12-28 2013-03-20 南京瑞尔医药有限公司 一种稳定的孟鲁司特钠片剂及制备方法
TWI658842B (zh) * 2014-03-31 2019-05-11 日商東麗股份有限公司 固體製劑用之被覆劑以及由其所形成之被膜及被覆固體製劑
JP7194524B2 (ja) * 2018-06-25 2022-12-22 日本酢ビ・ポバール株式会社 コーティング組成物並びに経口固形剤及びその製造方法
EP3846792A4 (fr) 2018-09-06 2022-10-12 Innopharmascreen Inc. Procédés et compositions pour le traitement de l'asthme ou de la maladie de parkinson
US20210113715A1 (en) * 2018-09-14 2021-04-22 Cedars-Sinai Medical Center Targeted nanoparticles for diagnosing, detecting and treating cancer
US20250302753A1 (en) * 2022-05-18 2025-10-02 Towa Pharmaceutical Co Ltd Membrane-forming composition, membrane-like composition, and use of same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5157815A (en) * 1974-11-14 1976-05-20 Sumitomo Chemical Co Toijono seizohoho
JPS5942325A (ja) * 1982-09-03 1984-03-08 Dai Ichi Seiyaku Co Ltd コ−テイング用組成物及びコ−テイング製剤
JPS61186313A (ja) 1985-02-12 1986-08-20 Dainippon Pharmaceut Co Ltd バルプロ酸ナトリウム製剤
JP2803179B2 (ja) * 1989-06-28 1998-09-24 東洋紡績株式会社 被覆プラスチックフイルム
JPH03120211A (ja) 1989-10-04 1991-05-22 Earth Chem Corp Ltd 粒状カルニチン製剤
JP3817274B2 (ja) * 1992-07-29 2006-09-06 住友化学株式会社 積層ガスバリア材
DE670160T1 (de) * 1994-03-01 1996-03-14 Gergely, Gerhard, Dr., Wien Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung.
EP0771339B1 (fr) * 1994-07-12 2003-10-15 BPSI Holdings, Inc. Composition d'enrobage seche constituant une pellicule de protection contre l'humidite, procede d'enrobage de substrats l'utilisant et tablettes pharmaceutiques ainsi enrobees
US5773031A (en) 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
JP4938204B2 (ja) 2001-02-27 2012-05-23 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 貯蔵安定性を改良するための、医薬品配合物用被覆材料および結合材料
NL1018607C2 (nl) * 2001-07-20 2003-01-21 Friesland Brands Bv Vochtbarrière in voedingsmiddelen.
US7553853B2 (en) 2003-10-10 2009-06-30 Synthon Bv Solid-state montelukast
WO2005074893A1 (fr) 2004-02-03 2005-08-18 Chemagis Ltd. Formes amorphes stables de montelukast sodique
JP2007145717A (ja) 2005-11-24 2007-06-14 Eisai R & D Management Co Ltd フィルムコーティング製剤
ES2277563B1 (es) * 2005-12-29 2008-06-16 Nanobiomatters, S.L. Procedimiento de fabricacion de materiales nanocompuestos para aplicaciones multisectoriales.
EP1803457A1 (fr) * 2005-12-30 2007-07-04 Krka Tovarna Zdravil, D.D., Novo Mesto Composition pharmaceutique contenant du montelukast
CA2635841A1 (fr) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Formulations pharmaceutiques stables de montelukast sodique
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
US20090124657A1 (en) * 2007-08-14 2009-05-14 Ramesh Kappala Pharmaceutical compositions comprising montelukast
TWI438012B (zh) * 2008-12-25 2014-05-21 Toray Industries 固態製劑用之塗覆劑及使用其之固態製劑
KR101294648B1 (ko) 2009-03-27 2013-08-09 도레이 카부시키가이샤 피복 고형제제

Also Published As

Publication number Publication date
JPWO2011105539A1 (ja) 2013-06-20
US20120321677A1 (en) 2012-12-20
CA2785694C (fr) 2013-12-17
EP2540298A1 (fr) 2013-01-02
TW201136618A (en) 2011-11-01
KR20120098877A (ko) 2012-09-05
ES2552628T3 (es) 2015-12-01
JP5761018B2 (ja) 2015-08-12
CN102762205A (zh) 2012-10-31
HUE026633T2 (en) 2016-06-28
MX344141B (es) 2016-12-07
BR112012015923A2 (pt) 2020-09-08
SI2540298T1 (sl) 2016-02-29
MX2012007997A (es) 2012-08-23
EP2540298A4 (fr) 2014-04-09
KR101445671B1 (ko) 2014-09-29
EP2540298B1 (fr) 2015-11-04
US8658208B2 (en) 2014-02-25
TWI480067B (zh) 2015-04-11
WO2011105539A1 (fr) 2011-09-01
CN102762205B (zh) 2014-03-12
CA2785694A1 (fr) 2011-09-01

Similar Documents

Publication Publication Date Title
EP2580985A4 (fr) Dispositif d'application d'agent de traitement pour cheveux
ZA201307372B (en) Coated solid pharmaceutical preparation
GB201008912D0 (en) Biocidal coating composition
EP2561892A4 (fr) Préparation solide aisément administrable
EP2641891A4 (fr) Activateur de pkc-
PL2540298T3 (pl) Powlekany stały preparat
GB201008513D0 (en) Adaptahaus
PL2412369T3 (pl) Powlekany preparat stały
ZA201300106B (en) Particle coating preparation
GB201307109D0 (en) Release coating
GB201001385D0 (en) Cable-tidies
EP2588088A4 (fr) Formes solides
HUE036565T2 (hu) Szelegilin-tartalmú ragasztókészítmény
GB201005693D0 (en) Corcost-sco11
GB201004263D0 (en) Tribrush
LT2534277T (lt) Modulinis padengimo įrenginys
GB201004148D0 (en) Temporary protectve coating composition
GB201009684D0 (en) Odontalgic preparation
AU4536P (en) TB01 Tibouchina urvilleana
ZA201108714B (en) Coating composition
AU331233S (en) Powder applicator
GB201018904D0 (en) Applicator
GB201012776D0 (en) Sprayer
GB201010620D0 (en) i C U
GB201004261D0 (en) Autofiller